Sartorius and Nanotein Technologies partner to advance cell therapy manufacturing
Under an exclusive distribution agreement, Sartorius Stedim Biotech will offer Nanotein’s lead products globally
Under an exclusive distribution agreement, Sartorius Stedim Biotech will offer Nanotein’s lead products globally
FDA requests Sarepta Therapeutics to suspend distribution of Elevidys and places clinical trials on hold for multiple gene therapy products following 3 deaths
Phosphate-based excipients provide higher bulk densities and enable the reduction of the tablet sizes
This facility is capable of manufacturing, packaging, testing, storage and distribution of two types of complex dosage forms
This marks the fourth acquisition by Corona Remedies from multinational corporations
The agreement includes plans for distribution, technology transfer, local manufacturing, new pharmaceutical product development
GII is a leading investment firm with assets under management exceeding US$ 3.5 billion with presence across Saudi Arabia, UAE, Europe, USA and India
Apollo AyurVAID’s product line features clinically proven formulations certified safe by NABL-accredited laboratories for heavy metals, aflatoxins, microbial content
Subscribe To Our Newsletter & Stay Updated